Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 5.68 USD -0.53% Market Closed
Market Cap: $733.5m
Write Note Create Alert Ask AI

Wall St Price Targets

CTKB Price Forecast
Based on 6 analysts

-10% Downside
from $5.68 today

CTKB Analyst Rating
Based on 6 analysts

Strong buy
1 17%
Buy
1 17%
Hold
3 50%
Sell
1 17%
Strong sell
0 0%
Cytek Biosciences Inc Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
17% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 7%.

What are analyst estimates?

Gross Profit
Forecast

15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
15% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 8%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat

What are analyst estimates?

Continue CTKB Research

Summary
CTKB intrinsic value, competitors valuation, and company profile.
DCF Valuation
CTKB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CTKB stock valuation using valuation multiples.
Wall St Estimates
CTKB price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CTKB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Cytek Biosciences Inc listings:
F • EUR
8EQ
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CTKB's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for CTKB is 5.1 USD with a low forecast of 4.8 USD and a high forecast of 7.88 USD.

What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
7%

Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 7%.

What is the Gross Profit forecast for Cytek Biosciences Inc?
Projected CAGR
8%

Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 8%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.